Solu-Cortef



Indications and Reactions:

Role Indications Reactions
Primary
Asthma 26.5%
Premedication 11.3%
Crohn's Disease 8.3%
Adrenocortical Insufficiency Acute 5.9%
Adrenal Insufficiency 4.9%
Hypersensitivity 4.4%
Prophylaxis 4.4%
Pyrexia 4.4%
Pneumonia 3.4%
Urticaria 3.4%
Chemotherapy 2.9%
Interstitial Lung Disease 2.9%
Sepsis 2.9%
Facial Palsy 2.5%
Addison's Disease 2.0%
Drug Hypersensitivity 2.0%
Drug Use For Unknown Indication 2.0%
Isolated Adrenocorticotropic Hormone Deficiency 2.0%
Myelofibrosis 2.0%
Pulmonary Fibrosis 2.0%
Shock 26.0%
Urticaria 8.3%
Anaphylactic Shock 6.3%
Anaphylactic Reaction 5.2%
Asthma 5.2%
Wrong Technique In Drug Usage Process 5.2%
Pruritus 4.2%
Skin Irritation 4.2%
Bronchopulmonary Aspergillosis Allergic 3.1%
Erythema Multiforme 3.1%
Platelet Count Decreased 3.1%
Respiratory Arrest 3.1%
Reversible Posterior Leukoencephalopathy Syndrome 3.1%
Septic Shock 3.1%
Vision Blurred 3.1%
Visual Impairment 3.1%
Wheezing 3.1%
White Blood Cell Count Increased 3.1%
Acute Hepatic Failure 2.1%
Adrenocortical Insufficiency Acute 2.1%
Secondary
Crohn's Disease 17.0%
Prophylaxis 14.8%
Premedication 13.4%
Juvenile Arthritis 6.7%
Drug Use For Unknown Indication 5.6%
Prophylaxis Against Renal Transplant Rejection 4.9%
Acute Lymphocytic Leukaemia 4.6%
Rheumatoid Arthritis 3.5%
Acute Myeloid Leukaemia 3.2%
Acute Myelomonocytic Leukaemia 3.2%
Asthma 2.8%
Infection Prophylaxis 2.6%
Pain 2.6%
Prophylaxis Against Graft Versus Host Disease 2.3%
Pyrexia 2.3%
Cancer Pain 2.1%
Constipation 2.1%
Interstitial Lung Disease 2.1%
Pneumonia 2.1%
Pneumonia Aspiration 2.1%
Reversible Posterior Leukoencephalopathy Syndrome 13.3%
Vomiting 13.3%
Urticaria 8.4%
Herpes Zoster 6.0%
Dyspnoea 4.8%
Shock 4.8%
Tuberculosis 4.8%
Anaphylactic Shock 3.6%
Cerebral Haemorrhage 3.6%
Erythema Multiforme 3.6%
Hepatic Function Abnormal 3.6%
Oxygen Saturation Decreased 3.6%
Pallor 3.6%
Pyrexia 3.6%
Skin Reaction 3.6%
Ureteric Obstruction 3.6%
Weight Decreased 3.6%
White Blood Cell Count Decreased 3.6%
Convulsion 2.4%
Endotoxic Shock 2.4%
Concomitant
Premedication 24.1%
Product Used For Unknown Indication 15.8%
Drug Use For Unknown Indication 12.5%
Prophylaxis 11.3%
Crohn's Disease 8.4%
Multiple Myeloma 3.2%
Hypertension 3.1%
Rheumatoid Arthritis 2.9%
Stem Cell Transplant 2.1%
Pain 2.0%
Colitis Ulcerative 2.0%
Infection Prophylaxis 1.8%
Constipation 1.7%
Acute Myeloid Leukaemia 1.5%
Nausea 1.5%
Sedation 1.5%
Insomnia 1.3%
Myelodysplastic Syndrome 1.1%
Gout 1.1%
Analgesic Therapy 1.0%
Vomiting 12.1%
Pneumonia 9.5%
Infusion Related Reaction 9.1%
Sepsis 8.8%
White Blood Cell Count Decreased 7.4%
Pyrexia 6.7%
Urticaria 6.7%
Death 4.2%
Rash 4.2%
Renal Failure 3.8%
Nausea 3.5%
Thrombocytopenia 3.3%
Dyspnoea 3.2%
Weight Increased 3.0%
Platelet Count Decreased 2.6%
Shock 2.6%
White Blood Cell Count Increased 2.6%
Renal Impairment 2.3%
Urinary Tract Infection 2.3%
Crohn's Disease 2.1%
Interacting
Crohn's Disease 100.0%
Sepsis 100.0%